
Biologics World Taiwan 2014
26 – 27 February 2014, Taipei, Taiwan
Event highlights:
· The most targeted platform to meet Taiwanese and international biologics manufacturers
· Case studies and discussions from senior level decision makers who will influence the direction of Taiwan's biologics industry
· Both strategic and technology-focused biologics development in Taiwan
Key topics include:
· Opportunities and challenges facing Taiwan's Biologics Industry
· Innovation highlights: Biobetters and novel biologics development in Taiwan
· Innovation highlights: Vaccine Development in Taiwan
· Biomanufacturing upstream best practices
· Biomanufacturing downstream best practices
· Operational excellence and PAT
· Crystalballing the future of Taiwan's biologics industry
Conference programme:
Taiwanese and international biopharmas, biotechs, CMOs, CROs and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices and capitalize on the potential of Taiwan’s growing biologic industry.
Take a look at the program overview
Day 1 (26-Feb-2014) |
Day 2 (27-Feb-2014) |
Morning Session |
Taiwan's Biologics Industry Landscape |
Biosimilars and Novel Biologics Development |
Biosimilars regulations and Market Access Strategies |
Bioprocessing and Scale-up Best Practices I |
Afternoon Session |
Strategies for Market Expansion through Partnerships |
Upstream Bioprocessing and Scale-up Best Practices II |
Crossing the strait: From Taiwan to the Mainland |
Panel Discussion: Bridging the Upstream & Downstream Workflow |
Conference Closes | Welcome Cocktails |
Key speakers include:
Dou Chang Lin, Chief Technology Officer, Biologic R&D, Luye Pharma Group
Karen Wen, President, Mycenax Biotech, Taiwan
Racho Jordanov, Founder, President and CEO, JHL Biotech
Yariv Hefez, Vice President of Business Development, Strategy, Portfolio Management and Partnering, Merck Serono
Dr. Jimmy Zhang, Managing Director, MSD Early Investments
Dr. Youe-Kong Shue, Vice Chairman, OBI
Juine-Ruey Chen, Head of R&D, Adimmune
Dr Carl Firth, CEO, ASLAN Pharmaceuticals
Dr Ko-Chung Lin, Founder and Chief Executive Officer, PharmaEssentia, Taiwan, and many more
Sponsorship information
Your business is about much more than just knocking on doors. Your marketing strategy is much more than a lead generator. To generate sales in Taiwan, you need a Taiwan-oriented platform and genuine leadership position. To generate awareness and response, you need targeted, decision-maker focused, geographically effective marketing. To generate profits, you need marketing service of Biologics World Taiwan 2014!
Biologics World Taiwan 2014 will give you the unique opportunity to position your business in front of decision makers from the world's largest and most innovative companies involved in biomanufacturing,cell culture development and engineering, vaccine R&D and manufacturing, investment andfinancing, stem cells, blood products and many more!
Contact information